BANGKOK, THAILAND – A landmark reform in Thailand’s healthcare system will allow patients from private clinics to purchase prescription medicines at external pharmacies from early November, ending decades of price control by hospitals.
Prescription freedom begins 4 November
The initiative, called “Suk-Kai Sabai-Krapao” — translated as Healthy Body, Comfortable Wallet — will take effect on 4 November. It is designed to give patients both financial relief and the freedom to choose where to buy their medication. Until now, those treated in private clinics were obliged to purchase drugs directly from the same facility, often at markedly higher prices.
According to the Thai Food and Drug Administration (FDA), more than 3,400 pharmacies have already registered to participate. With over 20,000 licensed pharmacies nationwide eligible to join voluntarily, officials see the high early uptake as a signal of strong support from the industry.
How the new system works
Once a patient leaves a private clinic with a prescription, they can take it to any participating pharmacy. The medicine will then be priced according to the pharmacy’s retail rate — typically much lower than hospital prices.
Supatra Boonserm, the FDA’s Secretary-General, confirmed that each participating pharmacy must operate under strict safety standards. “Throughout opening hours, a licensed pharmacist must be on site, and prescribed drugs must be procurable within 24 hours,” she said. The conditions, she explained, are intended to ensure public confidence and consistent quality across all outlets.
Digital tools to guide patients
To simplify the rollout, authorities will launch a website and mobile app named “Pharmacy Near Me” alongside the programme. The app enables users to:
• Locate authorized pharmacies in real time
• Check opening hours and responsible pharmacists
• Verify stock availability of specific drugs before traveling
“We advise patients to take their prescriptions to a participating pharmacy that is already fully prepared to issue medicines to avoid inconvenience,” Supatra noted. The official signing ceremony and launch event will take place at the Government House in Bangkok.
Safety and oversight remain priorities
While the plan gives consumers new flexibility, the FDA stressed that patient safety remains paramount. Pharmacies may dispense only the drugs listed on the physician’s prescription. Substituting brands for cheaper equivalents is allowed only with explicit consent from both the patient and the prescribing clinic.
Certain categories of drugs — including injections, controlled substances, and narcotics — remain exempt from the reform and must continue to be dispensed within clinical facilities.
Oversight of the scheme will fall to a joint monitoring committee composed of representatives from the FDA, public health services, and the Private Hospital Association. The group will evaluate implementation and swiftly address any arising issues.
Balancing affordability and trust
Thai authorities describe the measure as a balance between affordability and safety. Officials argue that reducing the financial pressure from high medicine costs could make private medical care more accessible across the country, particularly in urban centers where private clinics dominate.
The reform also signals a broader trend of regulatory modernization in Thailand’s healthcare sector — one that prioritizes transparency, efficiency, and equitable access to treatment options.
The coming weeks will reveal whether this ambitious initiative achieves its goal: lowering drug costs for millions of Thais without compromising care quality.